Clinical trials: Early Stage Triple-Negative Breast Carcinoma

Triple Negative Breast Cancer, Breast Cancer Stage II

Implantable Microdevice for TNBC - Pilot Study

• Withdrawn
• Age: 18 years and older
• Phase 1

The goal of this research study is to evaluate the safety and feasibility of implanting and retrieving a microdevice that releases microdoses of a specific drug or combination of drugs as a possible tool to evaluate the…

Conditions

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer

Trial name

NCT05774886

Testing

Implantable Microdevice (IMD)

Sponsor

Dana-Farber Cancer Institute